Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery by Bucci FA Jr, Evans RE, Amico LM, Morris TW, Fluet AT, Sanfilippo CM, DeCory HH, Comstock TL

Get full text

Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization by Taquet, M, Skorniewska, Z, Hampshire, A, Chalmers, JD, Ho, L-P, Horsley, A, Marks, M, Poinasamy, K, Raman, B, Leavy, OC, Richardson, M, Elneima, O, McAuley, HJC, Shikotra, A, Singapuri, A, Sereno, M, Saunders, RM, Harris, VC, Houchen-Wolloff, L, Greening, NJ, Mansoori, P, Harrison, EM, Docherty, AB, Lone, NI, Quint, J, Sattar, N, Brightling, CE, Wain, LV, Evans, RE, Geddes, JR, Harrison, PJ

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury by Taquet, M, Skorniewska, Z, Zetterberg, H, Geddes, JR, Mummery, CJ, Chalmers, JD, Ho, L-P, Horsley, A, Marks, M, Poinasamy, K, Raman, B, Leavy, OC, Richardson, M, Elneima, O, McAuley, HJC, Shikotra, A, Singapuri, A, Sereno, M, Saunders, RM, Harris, VC, Houchen-Wolloff, L, Mansoori, P, Greening, NJ, Harrison, EM, Docherty, AB, Lone, NI, Quint, J, Greenhalf, W, Wain, LV, Brightling, CE, Evans, RE, Harrison, PJ, Koychev, I